Overview
This entry refers to a form of Beckwith-Wiedemann syndrome (BWS) that was previously thought to be caused by mutations in the NSD1 gene. However, this classification is now considered obsolete, meaning the medical community no longer recognizes it as a distinct condition. The reason it was retired is that patients with NSD1 mutations who appeared to have Beckwith-Wiedemann syndrome were later found to actually have Sotos syndrome, a different overgrowth condition. Both conditions can share overlapping features such as large body size at birth, advanced bone age, and distinctive facial features, which initially caused diagnostic confusion. Beckwith-Wiedemann syndrome itself is an overgrowth disorder present from birth. It typically causes a large tongue (macroglossia), abdominal wall defects such as an omphalocele, enlarged organs, low blood sugar in newborns, and an increased risk of childhood tumors like Wilms tumor and hepatoblastoma. Classic BWS is caused by genetic or epigenetic changes on chromosome 11p15.5, not by NSD1 mutations. Sotos syndrome, which is the condition actually caused by NSD1 mutations, features overgrowth, a characteristic facial appearance with a long face and prominent forehead, intellectual disability, and advanced bone age. If you or your child received this specific diagnosis, it is important to speak with a clinical geneticist to clarify whether the correct diagnosis is Sotos syndrome or classic Beckwith-Wiedemann syndrome, as the management and tumor surveillance recommendations differ between these two conditions.
Key symptoms:
Large body size at birthLarge tongue that may stick out of the mouthAbdominal wall defects such as omphalocele or umbilical herniaLow blood sugar in newbornsEnlarged internal organsEar creases or pitsAdvanced bone ageTall stature for ageDistinctive facial featuresIncreased risk of childhood tumorsLearning difficulties or intellectual disabilityProminent forehead
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for OBSOLETE: Beckwith-Wiedemann syndrome due to NSD1 mutation.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for OBSOLETE: Beckwith-Wiedemann syndrome due to NSD1 mutation at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for OBSOLETE: Beckwith-Wiedemann syndrome due to NSD1 mutation.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to OBSOLETE: Beckwith-Wiedemann syndrome due to NSD1 mutation.
Community
No community posts yet. Be the first to share your experience with OBSOLETE: Beckwith-Wiedemann syndrome due to NSD1 mutation.
Start the conversation →Latest news about OBSOLETE: Beckwith-Wiedemann syndrome due to NSD1 mutation
No recent news articles for OBSOLETE: Beckwith-Wiedemann syndrome due to NSD1 mutation.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.Is my child's diagnosis truly Beckwith-Wiedemann syndrome, or could it be Sotos syndrome or another overgrowth condition?,What specific genetic testing has been done, and should additional testing be performed to clarify the diagnosis?,What tumor screening schedule should we follow, and for how long?,What developmental milestones should I watch for, and when should I seek early intervention services?,Are there any dietary or blood sugar monitoring needs I should be aware of?,What is the chance this condition could occur again in future pregnancies?,Can you refer us to a multidisciplinary team experienced with overgrowth syndromes?
Common questions about OBSOLETE: Beckwith-Wiedemann syndrome due to NSD1 mutation
What is OBSOLETE: Beckwith-Wiedemann syndrome due to NSD1 mutation?
This entry refers to a form of Beckwith-Wiedemann syndrome (BWS) that was previously thought to be caused by mutations in the NSD1 gene. However, this classification is now considered obsolete, meaning the medical community no longer recognizes it as a distinct condition. The reason it was retired is that patients with NSD1 mutations who appeared to have Beckwith-Wiedemann syndrome were later found to actually have Sotos syndrome, a different overgrowth condition. Both conditions can share overlapping features such as large body size at birth, advanced bone age, and distinctive facial features
How is OBSOLETE: Beckwith-Wiedemann syndrome due to NSD1 mutation inherited?
OBSOLETE: Beckwith-Wiedemann syndrome due to NSD1 mutation follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does OBSOLETE: Beckwith-Wiedemann syndrome due to NSD1 mutation typically begin?
Typical onset of OBSOLETE: Beckwith-Wiedemann syndrome due to NSD1 mutation is neonatal. Age of onset can vary across affected individuals.